GSK PLC - stock earnings
GLAXF Upcoming estimated earnings
Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
---|---|---|---|---|
July 31, 2024 BeforeMarket | - / - | 11.6 billion | - / 11.7 billion | 11.8 billion |
GLAXF Quarterly earnings
Date | Earnings | Revenue |
---|---|---|
2024Q1 | 1.3 billion USD | 9.3 billion USD |
2023Q4 | 445.9 million USD | 10.3 billion USD |
2023Q3 | 1.8 billion USD | 9.9 billion USD |
2023Q2 | 2.1 billion USD | 9.1 billion USD |
2023Q1 | 1.8 billion USD | 8.6 billion USD |
2022Q4 | 1.8 billion USD | 8.9 billion USD |
2022Q3 | 12.0 billion USD | 8.7 billion USD |
2022Q2 | 1.0 billion USD | 8.4 billion USD |
2022Q1 | 2.4 billion USD | 12.8 billion USD |
2021Q4 | 1.0 billion USD | 12.9 billion USD |
2021Q3 | 1.6 billion USD | 12.2 billion USD |
2021Q2 | 1.9 billion USD | 11.2 billion USD |
2021Q1 | 1.5 billion USD | 10.2 billion USD |
2020Q4 | 925.6 million USD | 11.9 billion USD |
2020Q3 | 1.6 billion USD | 11.2 billion USD |
2020Q2 | 2.8 billion USD | 9.4 billion USD |
2020Q1 | 1.9 billion USD | 11.2 billion USD |
2019Q4 | 1.7 billion USD | 11.7 billion USD |
2019Q3 | 1.9 billion USD | 11.6 billion USD |
2019Q2 | 1.2 billion USD | 9.9 billion USD |
2019Q1 | 1.1 billion USD | 10.0 billion USD |
2018Q4 | 1.5 billion USD | 10.4 billion USD |
2018Q3 | 1.9 billion USD | 10.6 billion USD |
2018Q2 | 576.6 million USD | 9.6 billion USD |
2018Q1 | 770.3 million USD | 10.1 billion USD |
2017Q4 | -734.0 million USD | 10.3 billion USD |
2017Q3 | 1.6 billion USD | 10.5 billion USD |
2017Q2 | -234.3 million USD | 9.5 billion USD |
2017Q1 | 1.3 billion USD | 9.2 billion USD |
2016Q4 | 317.2 million USD | 9.4 billion USD |
2016Q3 | 1.0 billion USD | 9.8 billion USD |
2016Q2 | -585.9 million USD | 8.8 billion USD |
2016Q1 | 405.4 million USD | 9.0 billion USD |
2015Q4 | -524.6 million USD | 9.3 billion USD |
2015Q3 | 815.7 million USD | 9.3 billion USD |
2015Q2 | 234.5 million USD | 9.3 billion USD |
2015Q1 | 12.0 billion USD | 8.3 billion USD |
2014Q4 | 1.6 billion USD | 9.6 billion USD |
2014Q3 | 651.4 million USD | 9.2 billion USD |
2014Q2 | 1.1 billion USD | 9.5 billion USD |
2014Q1 | 1.1 billion USD | 9.3 billion USD |
2013Q4 | 4.1 billion USD | 11.4 billion USD |
2013Q3 | 1.6 billion USD | 10.5 billion USD |
2013Q2 | 1.6 billion USD | 10.1 billion USD |
2013Q1 | 1.5 billion USD | 9.8 billion USD |
2012Q4 | 1.4 billion USD | 11.0 billion USD |
2012Q3 | 1.8 billion USD | 10.6 billion USD |
2012Q2 | 1.9 billion USD | 10.0 billion USD |
2012Q1 | 2.1 billion USD | 10.6 billion USD |
2011Q4 | 1.9 billion USD | 10.8 billion USD |
2011Q3 | 2.2 billion USD | 11.1 billion USD |
2011Q2 | 1.8 billion USD | 10.8 billion USD |
2011Q1 | 2.5 billion USD | 10.6 billion USD |
2010Q4 | -1.1 billion USD | 11.1 billion USD |
2010Q3 | 2.0 billion USD | 10.8 billion USD |
2010Q2 | -454.4 million USD | 10.5 billion USD |
2010Q1 | 2.0 billion USD | 11.2 billion USD |
2009Q4 | 2.6 billion USD | 13.1 billion USD |
2009Q3 | 2.1 billion USD | 10.8 billion USD |
2009Q2 | 2.4 billion USD | 11.1 billion USD |
2009Q1 | 1.6 billion USD | 9.7 billion USD |
2008Q4 | 1.5 billion USD | 10.1 billion USD |
2008Q3 | 1.9 billion USD | 10.5 billion USD |
2008Q2 | 2.6 billion USD | 11.7 billion USD |
2008Q1 | 2.6 billion USD | 11.3 billion USD |
2007Q4 | 2.1 billion USD | 11.9 billion USD |
2007Q3 | 2.7 billion USD | 11.2 billion USD |
2007Q2 | 2.7 billion USD | 11.4 billion USD |
2007Q1 | 3.0 billion USD | 11.0 billion USD |
2006Q4 | 2.3 billion USD | 11.7 billion USD |
2006Q3 | 2.6 billion USD | 10.6 billion USD |
2006Q2 | 2.4 billion USD | 10.8 billion USD |
2006Q1 | 2.6 billion USD | 10.1 billion USD |
2005Q4 | 1.9 billion USD | 10.2 billion USD |
2005Q3 | 2.1 billion USD | 9.7 billion USD |
2005Q2 | 2.1 billion USD | 9.4 billion USD |
2005Q1 | 2.3 billion USD | 9.5 billion USD |
2004Q4 | 2.3 billion USD | 10.8 billion USD |
2004Q3 | 1.8 billion USD | 8.9 billion USD |
2004Q2 | 2.0 billion USD | 9.1 billion USD |
2004Q1 | 1.9 billion USD | 9.0 billion USD |
2003Q4 | 1.4 billion USD | 9.6 billion USD |
2003Q3 | 1.9 billion USD | 9.1 billion USD |
2003Q2 | 2.2 billion USD | 8.7 billion USD |
2003Q1 | 1.9 billion USD | 8.3 billion USD |
2002Q4 | 1.5 billion USD | 9.1 billion USD |
2002Q3 | 1.2 billion USD | 7.9 billion USD |
2002Q2 | 1.8 billion USD | 8.4 billion USD |
2002Q1 | 1.5 billion USD | 7.3 billion USD |
2001Q4 | 1.4 billion USD | 8.2 billion USD |
2001Q3 | 558.0 million USD | 7.4 billion USD |
2001Q2 | 1.5 billion USD | 7.2 billion USD |
2001Q1 | 1.0 billion USD | 6.8 billion USD |
2000Q4 | 2.6 billion USD | 7.5 billion USD |
2000Q3 | 1.1 billion USD | 6.5 billion USD |
2000Q2 | 1.3 billion USD | 6.9 billion USD |
2000Q1 | 1.3 billion USD | 6.5 billion USD |
1999Q4 | 742.0 million USD | 3.7 billion USD |
1999Q3 | 574.3 million USD | 2.9 billion USD |
1999Q2 | 584.1 million USD | 2.6 billion USD |
1999Q1 | 572.0 million USD | 2.5 billion USD |
1998Q4 | 633.2 million USD | 2.6 billion USD |
1998Q3 | 631.3 million USD | 2.6 billion USD |
1998Q2 | 517.7 million USD | 2.4 billion USD |
1998Q1 | 517.6 million USD | 2.4 billion USD |
1997Q4 | 476.1 million USD | 2.3 billion USD |
1997Q3 | 523.3 million USD | 2.5 billion USD |
1997Q2 | 640.8 million USD | 2.5 billion USD |
1997Q1 | 651.1 million USD | 2.6 billion USD |
1996Q4 | 1.1 billion USD | 4.2 billion USD |
1996Q3 | 146.1 million USD | 3.1 billion USD |
1996Q2 | 652.8 million USD | 2.6 billion USD |
1996Q1 | 664.1 million USD | 2.7 billion USD |
1995Q3 | 327.4 million USD | 2.0 billion USD |
1995Q2 | 338.7 million USD | 2.1 billion USD |
1995Q1 | 321.0 million USD | 2.0 billion USD |
1994Q4 | 331.5 million USD | 2.1 billion USD |
1994Q3 | 328.1 million USD | 2.0 billion USD |
1994Q2 | 332.5 million USD | 1.6 billion USD |
1994Q1 | 397.0 million USD | 1.9 billion USD |
1993Q4 | 451.7 million USD | 1.8 billion USD |
1993Q3 | 442.6 million USD | 1.7 billion USD |
1993Q2 | 319.8 million USD | 1.4 billion USD |
1993Q1 | 446.7 million USD | 1.9 billion USD |
1992Q4 | 367.0 million USD | 1.4 billion USD |
1992Q3 | 312.9 million USD | 1.2 billion USD |
1992Q2 | 232.5 million USD | 922.1 million USD |
1992Q1 | 353.7 million USD | 1.4 billion USD |
1991Q4 | 329.0 million USD | 1.3 billion USD |
1991Q3 | 351.1 million USD | 1.4 billion USD |
1991Q2 | ? USD | 1.3 billion USD |
1991Q1 | ? USD | 993.6 million USD |
1990Q4 | ? USD | 895.5 million USD |
1990Q3 | ? USD | 920.9 million USD |
1990Q2 | ? USD | 1.2 billion USD |
1990Q1 | ? USD | 982.0 million USD |
1989Q4 | ? USD | 942.7 million USD |
1989Q3 | ? USD | 931.5 million USD |
1989Q2 | ? USD | 988.3 million USD |
1989Q1 | ? USD | 728.7 million USD |
1988Q4 | ? USD | 703.9 million USD |
1988Q3 | ? USD | 752.1 million USD |
1988Q2 | ? USD | 807.8 million USD |
1988Q1 | ? USD | 601.8 million USD |
1987Q4 | ? USD | 580.5 million USD |
1987Q3 | ? USD | 667.7 million USD |
1987Q2 | ? USD | 578.2 million USD |
1987Q1 | ? USD | 580.7 million USD |
1986Q4 | ? USD | 554.7 million USD |
1986Q3 | ? USD | 565.9 million USD |
1986Q2 | ? USD | 377.5 million USD |
1986Q1 | ? USD | 470.7 million USD |
1985Q4 | ? USD | 478.2 million USD |
1985Q3 | ? USD | 491.5 million USD |
GLAXF Yearly earnings
Date | Earnings | Revenue |
---|---|---|
2023 | 6.3 billion USD | 38.6 billion USD |
2022 | 18.1 billion USD | 35.5 billion USD |
2021 | 5.9 billion USD | 46.1 billion USD |
2020 | 7.9 billion USD | 46.6 billion USD |
2019 | 6.1 billion USD | 44.3 billion USD |
2018 | 4.6 billion USD | 39.1 billion USD |
2017 | 2.1 billion USD | 40.6 billion USD |
2016 | 1.1 billion USD | 34.4 billion USD |
2015 | 12.5 billion USD | 35.5 billion USD |
2014 | 4.3 billion USD | 35.8 billion USD |
2013 | 9.0 billion USD | 43.7 billion USD |
2012 | 7.4 billion USD | 42.9 billion USD |
2011 | 8.1 billion USD | 42.2 billion USD |
2010 | 2.5 billion USD | 43.8 billion USD |
2009 | 8.9 billion USD | 45.9 billion USD |
2008 | 6.9 billion USD | 35.6 billion USD |
2007 | 10.4 billion USD | 45.1 billion USD |
2006 | 10.6 billion USD | 45.5 billion USD |
2005 | 8.1 billion USD | 37.3 billion USD |
2004 | 7.5 billion USD | 38.4 billion USD |
2003 | 8.0 billion USD | 38.4 billion USD |
2002 | 6.3 billion USD | 34.1 billion USD |
2001 | 4.5 billion USD | 29.6 billion USD |
2000 | 6.2 billion USD | 27.0 billion USD |
1999 | 2.9 billion USD | 13.7 billion USD |
1998 | 2.3 billion USD | 10.0 billion USD |
1997 | 2.3 billion USD | 10.0 billion USD |
1996 | 2.5 billion USD | 10.4 billion USD |
1995 | 1.8 billion USD | 13.1 billion USD |
1993 | 1.6 billion USD | 7.1 billion USD |
1992 | 1.5 billion USD | 6.2 billion USD |
1991 | 1.3 billion USD | 5.1 billion USD |
1990 | 1.1 billion USD | 4.3 billion USD |
1989 | 1.0 billion USD | 4.0 billion USD |
1988 | 861.7 million USD | 3.2 billion USD |
1987 | 727.6 million USD | 2.6 billion USD |
1986 | 638.7 million USD | 2.2 billion USD |
1985 | 501.0 million USD | 1.8 billion USD |
GLAXF
Price: $22.54
Dividend Yield: 3.35%
Forward Dividend Yield: 3.36%
Payout Ratio: 46.93%
Dividend Per Share: 0.76 USD
Earnings Per Share: 1.36 USD
P/E Ratio: 13.91
Exchange: PNK
Sector: Healthcare
Industry: Drug Manufacturers - General
Market Capitalization: 92.2 billion
Average Dividend Frequency: 4
Years Paying Dividends: 21
DGR3: -10.06%
DGR5: -6.61%
DGR10: 1.83%